These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Evaluation of basal sex hormone levels for activation of the hypothalamic-pituitary-gonadal axis. Ding Y; Li J; Yu Y; Yang P; Li H; Shen Y; Huang X; Liu S J Pediatr Endocrinol Metab; 2018 Mar; 31(3):323-329. PubMed ID: 29466239 [TBL] [Abstract][Full Text] [Related]
25. The effect of medroxyprogesterone acetate on gonadotropin secretion in girls with precocious puberty. Warren MP; Mathews JH; Morishima A; Vande Wiele R Am J Med Sci; 1975; 269(3):375-81. PubMed ID: 1155493 [TBL] [Abstract][Full Text] [Related]
26. A sporadic case of male-limited precocious puberty has the same constitutively activating point mutation in luteinizing hormone/choriogonadotropin receptor gene as familial cases. Yano K; Hidaka A; Saji M; Polymeropoulos MH; Okuno A; Kohn LD; Cutler GB J Clin Endocrinol Metab; 1994 Dec; 79(6):1818-23. PubMed ID: 7527413 [TBL] [Abstract][Full Text] [Related]
27. Effectiveness of basal LH in monitoring central precocious puberty treatment in girls. Calcaterra V; De Filippo G; Albertini R; Rendina D; Messini B; Monti CM; Bozzola E; Villani A; Bozzola M J Pediatr Endocrinol Metab; 2021 Jan; 34(1):45-50. PubMed ID: 33189082 [TBL] [Abstract][Full Text] [Related]
28. Role of gonadal negative feedback on the gonadotrophin responses to gonadotrophin-releasing hormone (GnRH) in ram lambs from two lines of sheep selected for their luteinizing hormone response to GnRH. Evans NP; Land RB; McNeilly JR; Webb R J Reprod Fertil; 1991 Nov; 93(2):549-58. PubMed ID: 1787476 [TBL] [Abstract][Full Text] [Related]
29. Boys with precocious puberty due to hypothalamic hamartoma: reproductive axis after discontinuation of gonadotropin-releasing hormone analog therapy. Feuillan PP; Jones JV; Barnes KM; Oerter-Klein K; Cutler GB J Clin Endocrinol Metab; 2000 Nov; 85(11):4036-8. PubMed ID: 11095429 [TBL] [Abstract][Full Text] [Related]
30. Responsivity of pituitary gonadotropes to luteinizing hormone-releasing factor in idiopathic precocious puberty, precocious thelarche, precocious adrenarche, and in patients treated with medroxyprogesterone acetate. Reiter EO; Kaplan SL; Conte FA; Grumbach MM Pediatr Res; 1975 Feb; 9(2):111-6. PubMed ID: 1090891 [TBL] [Abstract][Full Text] [Related]
31. Hypogonadotropic hypogonadism in severe beta-thalassemia: effect of chelation and pulsatile gonadotropin-releasing hormone therapy. Wang C; Tso SC; Todd D J Clin Endocrinol Metab; 1989 Mar; 68(3):511-6. PubMed ID: 2493034 [TBL] [Abstract][Full Text] [Related]
33. Gonadotropin-independent familial sexual precocity with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent luteinizing hormone-releasing factor agonist and medroxyprogesterone acetate therapy in four cases. Rosenthal SM; Grumbach MM; Kaplan SL J Clin Endocrinol Metab; 1983 Sep; 57(3):571-9. PubMed ID: 6223935 [TBL] [Abstract][Full Text] [Related]
34. Irreversible increase of serum IGF-1 and IGFBP-3 levels in GnRH-dependent precocious puberty of different etiologies: implications for the onset of puberty. Belgorosky A; Rivarola MA Horm Res; 1998; 49(5):226-32. PubMed ID: 9568807 [TBL] [Abstract][Full Text] [Related]
35. The relationship between luteinizing hormone and estradiol secretion in female precocious puberty: evaluation by sensitive gonadotropin assays and the leuprolide stimulation test. Garibaldi LR; Aceto T; Weber C; Pang S J Clin Endocrinol Metab; 1993 Apr; 76(4):851-6. PubMed ID: 8473395 [TBL] [Abstract][Full Text] [Related]
36. Testicular adrenal rests: evidence for luteinizing hormone receptors and for distinct types of testicular nodules differing for their autonomization. Benvenga S; Smedile G; Lo Giudice F; Trimarchi F Eur J Endocrinol; 1999 Sep; 141(3):231-7. PubMed ID: 10474120 [TBL] [Abstract][Full Text] [Related]
37. The response of pituitary gonadotropes to a constant infusion of luteinizing hormone-releasing hormone (LHRH) in normal prepubertal and pubertal children and in children with abnormalities of sexual development. Reiter EO; Root AW; Duckett GE J Clin Endocrinol Metab; 1976 Aug; 43(2):400-11. PubMed ID: 780368 [TBL] [Abstract][Full Text] [Related]
38. Suppression of puberty with long-acting goserelin (Zoladex-LA): effect on gonadotrophin response to GnRH in the first treatment cycle. Trueman JA; Tillmann V; Cusick CF; Foster P; Patel L; Hall CM; Price DA; Clayton PE Clin Endocrinol (Oxf); 2002 Aug; 57(2):223-30. PubMed ID: 12153601 [TBL] [Abstract][Full Text] [Related]
39. Pituitary and gonadal function in prepubertal boys with hypospadias. Nonomura K; Fujieda K; Sakakibara N; Terasawa K; Matsuno T; Matsuura N; Koyanagi T J Urol; 1984 Sep; 132(3):595-8. PubMed ID: 6433046 [TBL] [Abstract][Full Text] [Related]
40. Maturation of the normal pituitary-testicular axis, as assessed by gonadotropin-releasing hormone agonist challenge. Ghai K; Rosenfield RL J Clin Endocrinol Metab; 1994 Jun; 78(6):1336-40. PubMed ID: 8200935 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]